O	O	O	0	13	Transcription	Transcription	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	14	20	factor	factor	I-NP	NN	I-protein	3	NMOD	I-protein
O	O	O	21	31	activation	activation	I-NP	NN	O	0	ROOT	O
O	O	O	32	34	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	35	45	lymphokine	lymphokine	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	O	46	55	activated	activated	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	O	56	62	killer	killer	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	O	63	68	cells	cell	I-NP	NNS	I-cell_type	10	NMOD	I-cell_type
O	O	O	69	72	and	and	O	CC	O	10	NMOD	O
O	O	O	73	84	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	4	PMOD	B-cell_type
O	O	O	85	89	from	from	B-PP	IN	O	10	NMOD	O
O	O	O	90	98	patients	patient	B-NP	NNS	O	11	PMOD	O
O	O	O	99	108	receiving	receive	B-VP	VBG	O	12	NMOD	O
T1	B-Protein	B-Protein	109	111	IL	IL	B-NP	NN	B-protein	17	NMOD	B-protein
T1	I-Protein	I-Protein	111	112	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T1	I-Protein	I-Protein	112	113	2	2	B-NP	CD	I-protein	17	NMOD	I-protein
O	O	O	114	127	immunotherapy	immunotherapy	I-NP	NN	O	13	OBJ	O
O	O	O	127	128	.	.	O	.	O	3	P	O

O	O	O	130	144	Administration	Administration	B-NP	NN	O	13	SUB	O
O	O	O	145	147	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	148	151	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	152	160	cytokine	cytokine	I-NP	NN	B-protein	5	NMOD	B-protein
T2	B-Protein	B-Protein	161	172	interleukin	interleukin	I-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Protein	I-Protein	172	173	-	-	B-NP	HYPH	O	2	PMOD	O
T2	I-Protein	I-Protein	173	174	2	2	I-NP	CD	O	6	NMOD	O
O	O	O	175	176	(	(	O	(	O	12	DEP	O
T3	B-Protein	B-Protein	176	178	IL	IL	B-NP	NN	B-protein	12	DEP	B-protein
T3	I-Protein	I-Protein	178	179	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T3	I-Protein	I-Protein	179	180	2	2	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	180	181	)	)	O	)	O	6	NMOD	O
O	O	O	182	185	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	186	192	result	result	I-VP	VB	O	13	VC	O
O	O	O	193	195	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	196	207	therapeutic	therapeutic	B-NP	JJ	O	17	NMOD	O
O	O	O	208	216	benefits	benefit	I-NP	NNS	O	15	PMOD	O
O	O	O	217	220	for	for	B-PP	IN	O	17	NMOD	O
O	O	O	221	232	individuals	individual	B-NP	NNS	O	18	PMOD	O
O	O	O	233	237	with	with	B-PP	IN	O	19	NMOD	O
O	O	O	238	243	renal	renal	B-NP	JJ	O	23	NMOD	O
O	O	O	244	248	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	O	249	258	carcinoma	carcinoma	I-NP	NN	O	25	NMOD	O
O	O	O	259	262	and	and	I-NP	CC	O	25	NMOD	O
O	O	O	263	271	melanoma	melanoma	I-NP	NN	O	20	PMOD	O
O	O	O	271	272	.	.	O	.	O	13	P	O

O	O	O	273	277	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	278	280	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	281	287	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	288	290	an	an	B-NP	DT	O	5	NMOD	O
O	O	O	291	299	analysis	analysis	I-NP	NN	O	10	SUB	O
O	O	O	300	302	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	303	306	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	307	320	transcription	transcription	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	321	327	factor	factor	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	328	336	families	family	B-VP	VBZ	O	3	VMOD	O
T16	B-Entity	B-Entity	337	339	AP	AP	B-NP	NN	B-protein	12	NMOD	B-protein
T16	I-Entity	I-Entity	339	340	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T16	I-Entity	I-Entity	340	341	1	1	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	341	342	,	,	O	,	O	12	P	O
T4	B-Protein	B-Protein	343	346	Sp1	Sp1	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	346	347	,	,	O	,	O	27	P	O
T17	B-Entity	B-Entity	348	350	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T17	I-Entity	I-Entity	350	351	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T17	I-Entity	I-Entity	351	357	kappaB	kappaB	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	357	358	,	,	O	,	O	27	P	O
O	O	O	359	362	and	and	O	CC	O	27	NMOD	O
O	O	O	363	369	signal	signal	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	370	381	transducers	transducer	I-NP	NNS	I-protein	27	NMOD	I-protein
O	O	O	382	385	and	and	O	CC	I-protein	27	NMOD	I-protein
O	O	O	386	396	activators	activator	B-NP	NNS	I-protein	27	NMOD	I-protein
O	O	O	397	399	of	of	B-PP	IN	I-protein	27	NMOD	I-protein
O	O	O	400	413	transcription	transcription	B-NP	NN	I-protein	10	OBJ	I-protein
O	O	O	414	415	(	(	O	(	O	30	DEP	O
O	O	O	415	419	STAT	STAT	B-NP	NN	B-protein	30	DEP	B-protein
O	O	O	419	420	)	)	O	)	O	27	NMOD	O
O	O	O	421	423	in	in	B-PP	IN	O	27	NMOD	O
O	O	O	424	430	cancer	cancer	B-NP	NN	B-cell_type	35	NMOD	B-cell_type
O	O	O	431	439	patients	patient	I-NP	NNS	I-cell_type	35	NMOD	I-cell_type
O	O	O	439	440	'	'	B-NP	POS	I-cell_type	35	NMOD	I-cell_type
O	O	O	441	452	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	31	PMOD	I-cell_type
O	O	O	453	459	before	before	B-PP	IN	O	27	NMOD	O
O	O	O	460	463	and	and	I-PP	CC	O	36	PMOD	O
O	O	O	464	469	after	after	I-PP	IN	O	36	PMOD	O
T5	B-Protein	B-Protein	470	472	IL	IL	B-NP	NN	B-protein	42	NMOD	B-protein
T5	I-Protein	I-Protein	472	473	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T5	I-Protein	I-Protein	473	474	2	2	I-NP	CD	I-protein	42	NMOD	I-protein
O	O	O	475	488	immunotherapy	immunotherapy	I-NP	NN	O	36	PMOD	O
O	O	O	488	489	,	,	O	,	O	10	P	O
O	O	O	490	492	as	as	B-SBAR	IN	O	10	VMOD	O
O	O	O	493	501	assessed	assess	B-VP	VBN	O	44	SBAR	O
O	O	O	502	504	by	by	B-PP	IN	O	45	VMOD	O
O	O	O	505	506	a	a	B-NP	DT	O	51	NMOD	O
O	O	O	507	510	gel	gel	I-NP	NN	O	51	NMOD	O
O	O	O	510	511	-	-	I-NP	HYPH	O	51	NMOD	O
O	O	O	511	516	shift	shift	I-NP	NN	O	51	NMOD	O
O	O	O	517	522	assay	assay	I-NP	NN	O	46	PMOD	O
O	O	O	522	523	.	.	O	.	O	3	P	O

O	O	O	524	526	An	An	B-NP	DT	O	4	NMOD	O
O	O	O	527	529	in	in	I-NP	FW	O	3	AMOD	O
O	O	O	530	535	vitro	vitro	I-NP	FW	O	4	NMOD	O
O	O	O	536	545	surrogate	surrogate	I-NP	NN	O	10	SUB	O
O	O	O	546	548	of	of	B-PP	IN	O	4	NMOD	O
T6	B-Protein	B-Protein	549	551	IL	IL	B-NP	NN	B-protein	9	NMOD	B-protein
T6	I-Protein	I-Protein	551	552	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T6	I-Protein	I-Protein	552	553	2	2	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	554	567	immunotherapy	immunotherapy	I-NP	NN	O	5	PMOD	O
O	O	O	568	570	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	571	574	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	575	585	incubation	incubation	I-NP	NN	O	10	PRD	O
O	O	O	586	588	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	589	594	fresh	fresh	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	595	605	peripheral	peripheral	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	606	611	blood	blood	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	O	612	623	mononuclear	mononuclear	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	624	629	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	630	631	(	(	O	(	O	21	DEP	O
O	O	O	631	635	PBMC	PBMC	B-NP	NN	B-cell_type	21	DEP	B-cell_type
O	O	O	635	636	)	)	O	)	O	18	NMOD	O
O	O	O	637	641	from	from	B-PP	IN	O	18	NMOD	O
O	O	O	642	649	healthy	healthy	B-NP	JJ	O	24	NMOD	O
O	O	O	650	661	individuals	individual	I-NP	NNS	O	22	PMOD	O
O	O	O	662	664	in	in	B-PP	IN	O	24	NMOD	O
T7	B-Protein	B-Protein	665	667	IL	IL	B-NP	NN	B-protein	25	PMOD	B-protein
T7	I-Protein	I-Protein	667	668	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T7	I-Protein	I-Protein	668	669	2	2	I-NP	CD	I-protein	26	NMOD	I-protein
O	O	O	670	673	for	for	B-PP	IN	O	24	NMOD	O
O	O	O	674	681	several	several	B-NP	JJ	O	31	NMOD	O
O	O	O	682	686	days	day	I-NP	NNS	O	29	PMOD	O
O	O	O	686	687	,	,	O	,	O	12	P	O
O	O	O	688	697	resulting	result	B-VP	VBG	O	12	NMOD	O
O	O	O	698	700	in	in	B-PP	IN	O	33	VMOD	O
O	O	O	701	704	the	the	B-NP	DT	O	36	NMOD	O
O	O	O	705	715	production	production	I-NP	NN	O	34	PMOD	O
O	O	O	716	718	of	of	B-PP	IN	O	36	NMOD	O
O	O	O	719	729	lymphokine	lymphokine	B-NP	NN	B-protein	41	NMOD	B-protein
O	O	O	729	730	-	-	B-NP	HYPH	O	41	NMOD	O
O	O	O	730	739	activated	activate	I-NP	VBN	O	41	NMOD	O
O	O	O	740	746	killer	killer	I-NP	NN	O	45	NMOD	O
O	O	O	747	748	(	(	O	(	O	44	DEP	O
O	O	O	748	751	LAK	LAK	B-NP	NN	B-protein	44	DEP	B-protein
O	O	O	751	752	)	)	O	)	O	41	NMOD	O
O	O	O	753	761	activity	activity	B-NP	NN	O	37	PMOD	O
O	O	O	762	764	in	in	B-PP	IN	O	45	NMOD	O
O	O	O	765	770	these	these	B-NP	DT	O	48	NMOD	O
O	O	O	771	779	cultures	culture	I-NP	NNS	O	46	PMOD	O
O	O	O	779	780	.	.	O	.	O	10	P	O

O	O	O	781	784	One	One	B-NP	CD	O	2	NMOD	O
O	O	O	785	792	purpose	purpose	I-NP	NN	O	6	SUB	O
O	O	O	793	795	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	796	800	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	801	806	study	study	I-NP	NN	O	3	PMOD	O
O	O	O	807	810	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	811	813	to	to	B-VP	TO	O	8	VMOD	O
O	O	O	814	822	describe	describe	I-VP	VB	O	6	PRD	O
O	O	O	823	826	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	827	834	profile	profile	I-NP	NN	O	8	OBJ	O
O	O	O	835	837	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	838	851	transcription	transcription	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	852	858	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	859	869	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	O	870	872	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	873	878	these	these	B-NP	DT	O	18	NMOD	O
O	O	O	879	888	different	different	I-NP	JJ	O	18	NMOD	O
O	O	O	889	900	populations	population	I-NP	NNS	O	15	PMOD	O
O	O	O	900	901	,	,	O	,	O	6	P	O
O	O	O	902	905	and	and	O	CC	O	6	VMOD	O
O	O	O	906	912	assess	assess	B-VP	VB	O	6	VMOD	O
O	O	O	913	920	whether	whether	B-SBAR	IN	O	21	VMOD	O
O	O	O	921	924	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	925	933	patterns	pattern	I-NP	NNS	O	26	SUB	O
O	O	O	934	942	observed	observe	B-VP	VBN	O	24	NMOD	O
O	O	O	943	953	correlated	correlate	B-VP	VBD	O	22	SBAR	O
O	O	O	954	958	with	with	B-PP	IN	O	26	VMOD	O
O	O	O	959	969	functional	functional	B-NP	JJ	O	29	NMOD	O
O	O	O	970	981	differences	difference	I-NP	NNS	O	27	PMOD	O
O	O	O	982	984	in	in	B-PP	IN	O	29	NMOD	O
O	O	O	985	990	these	these	B-NP	DT	O	32	NMOD	O
O	O	O	991	996	cells	cell	I-NP	NNS	O	30	PMOD	O
O	O	O	996	997	.	.	O	.	O	6	P	O

O	O	O	998	1003	Prior	Prior	B-ADVP	RB	O	21	VMOD	O
O	O	O	1004	1006	to	to	B-PP	TO	O	1	PMOD	O
O	O	O	1007	1009	in	in	B-NP	FW	O	4	AMOD	O
O	O	O	1010	1014	vivo	vivo	I-NP	FW	O	8	NMOD	O
T8	B-Protein	B-Protein	1015	1017	IL	IL	I-NP	NN	B-protein	8	NMOD	B-protein
T8	I-Protein	I-Protein	1017	1018	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T8	I-Protein	I-Protein	1018	1019	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	1020	1034	administration	administration	I-NP	NN	O	2	PMOD	O
O	O	O	1034	1035	,	,	O	,	O	21	P	O
O	O	O	1036	1039	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1040	1047	typical	typical	I-NP	JJ	O	13	NMOD	O
O	O	O	1048	1055	binding	binding	I-NP	NN	O	13	NMOD	O
O	O	O	1056	1063	pattern	pattern	I-NP	NN	O	21	SUB	O
O	O	O	1064	1066	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1067	1080	transcription	transcription	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	1081	1088	factors	factor	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	O	1089	1091	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	1092	1096	PBMC	PBMC	B-NP	NN	B-cell_type	17	PMOD	B-cell_type
O	O	O	1097	1101	from	from	B-PP	IN	O	18	NMOD	O
O	O	O	1102	1110	patients	patient	B-NP	NNS	O	19	PMOD	O
O	O	O	1111	1120	resembled	resemble	B-VP	VBD	O	0	ROOT	O
O	O	O	1121	1125	that	that	B-NP	DT	O	21	OBJ	O
O	O	O	1126	1130	seen	see	B-VP	VBN	O	22	NMOD	O
O	O	O	1131	1133	in	in	B-PP	IN	O	23	VMOD	O
O	O	O	1134	1139	fresh	fresh	B-NP	JJ	O	24	PMOD	O
O	O	O	1140	1144	PBMC	PBMC	I-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	O	1145	1149	from	from	B-PP	IN	O	25	NMOD	O
O	O	O	1150	1157	healthy	healthy	B-NP	JJ	O	29	NMOD	O
O	O	O	1158	1169	individuals	individual	I-NP	NNS	O	27	PMOD	O
O	O	O	1169	1170	.	.	O	.	O	21	P	O

O	O	O	1171	1175	Over	Over	B-PP	IN	O	31	VMOD	O
O	O	O	1176	1177	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	1178	1179	3	3	I-NP	CD	O	6	NMOD	O
O	O	O	1179	1180	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	O	1180	1184	week	week	I-NP	NN	O	6	NMOD	O
O	O	O	1185	1191	course	course	I-NP	NN	O	1	PMOD	O
O	O	O	1192	1194	of	of	B-PP	IN	O	6	NMOD	O
T9	B-Protein	B-Protein	1195	1197	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T9	I-Protein	I-Protein	1197	1198	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T9	I-Protein	I-Protein	1198	1199	2	2	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	1200	1207	therapy	therapy	I-NP	NN	O	7	PMOD	O
O	O	O	1207	1208	,	,	O	,	O	31	P	O
O	O	O	1209	1211	in	in	B-PP	IN	O	31	VMOD	O
O	O	O	1212	1216	most	most	B-NP	JJS	O	15	NMOD	O
O	O	O	1217	1225	patients	patient	I-NP	NNS	O	13	PMOD	O
O	O	O	1226	1229	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1230	1237	binding	binding	I-NP	NN	O	18	NMOD	O
O	O	O	1238	1246	patterns	pattern	I-NP	NNS	O	13	PMOD	O
O	O	O	1247	1249	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1250	1252	AP	AP	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1252	1253	-	-	B-NP	HYPH	I-protein	19	PMOD	I-protein
O	O	O	1253	1254	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	O	1255	1256	,	,	O	,	O	21	P	O
T10	B-Protein	B-Protein	1257	1260	Sp1	Sp1	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1260	1261	,	,	O	,	O	31	P	O
O	O	O	1262	1265	and	and	O	CC	O	31	VMOD	O
O	O	O	1266	1268	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	1268	1269	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
O	O	O	1269	1275	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	1276	1284	proteins	protein	I-NP	NNS	I-protein	31	SUB	I-protein
O	O	O	1285	1292	changed	change	B-VP	VBD	O	0	ROOT	O
O	O	O	1293	1295	to	to	I-VP	TO	O	33	VMOD	O
O	O	O	1296	1304	resemble	resemble	I-VP	VB	O	31	VMOD	O
O	O	O	1305	1310	those	those	B-NP	DT	O	33	OBJ	O
O	O	O	1311	1315	seen	see	B-VP	VBN	O	34	NMOD	O
O	O	O	1316	1318	in	in	B-PP	IN	O	35	VMOD	O
O	O	O	1319	1323	PBMC	PBMC	B-NP	NN	B-cell_type	36	PMOD	B-cell_type
O	O	O	1324	1333	activated	activate	B-VP	VBN	O	37	NMOD	O
O	O	O	1334	1336	by	by	B-PP	IN	O	38	VMOD	O
T11	B-Protein	B-Protein	1337	1339	IL	IL	B-NP	NN	B-protein	41	NMOD	B-protein
T11	I-Protein	I-Protein	1339	1340	-	-	B-NP	HYPH	I-protein	39	PMOD	I-protein
T11	I-Protein	I-Protein	1340	1341	2	2	I-NP	CD	I-protein	41	NMOD	I-protein
O	O	O	1342	1344	in	in	B-ADVP	FW	O	38	VMOD	O
O	O	O	1345	1350	vitro	vitro	I-ADVP	FW	O	43	AMOD	O
O	O	O	1350	1351	.	.	O	.	O	31	P	O

O	O	O	1352	1359	However	However	B-ADVP	RB	O	13	VMOD	O
O	O	O	1359	1360	,	,	O	,	O	13	P	O
O	O	O	1361	1364	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1365	1370	cells	cell	I-NP	NNS	O	13	SUB	O
O	O	O	1371	1379	obtained	obtain	B-VP	VBN	O	4	NMOD	O
O	O	O	1380	1384	from	from	B-PP	IN	O	5	VMOD	O
T12	B-Protein	B-Protein	1385	1387	IL	IL	B-NP	NN	B-protein	8	NMOD	B-protein
T12	I-Protein	I-Protein	1387	1388	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T12	I-Protein	I-Protein	1388	1389	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	1389	1390	-	-	O	HYPH	O	8	P	O
O	O	O	1390	1397	treated	treat	B-VP	VBN	O	12	NMOD	O
O	O	O	1398	1406	patients	patient	B-NP	NNS	O	6	PMOD	O
O	O	O	1407	1410	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	1411	1414	not	not	I-VP	RB	O	13	VMOD	O
O	O	O	1415	1419	have	have	I-VP	VB	O	13	VC	O
O	O	O	1420	1423	low	low	B-NP	JJ	O	20	NMOD	O
O	O	O	1423	1424	-	-	I-NP	HYPH	O	20	NMOD	O
O	O	O	1424	1429	level	level	I-NP	NN	O	20	NMOD	O
O	O	O	1430	1442	constitutive	constitutive	I-NP	JJ	O	20	NMOD	O
O	O	O	1443	1453	expression	expression	I-NP	NN	O	15	OBJ	O
O	O	O	1454	1456	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1457	1461	STAT	STAT	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	1462	1469	binding	binding	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	O	1470	1477	factors	factor	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	O	1478	1480	as	as	B-SBAR	IN	O	13	VMOD	O
O	O	O	1481	1484	did	do	B-VP	VBD	O	25	SBAR	O
O	O	O	1485	1488	LAK	LAK	B-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	O	1489	1494	cells	cell	I-NP	NNS	I-cell_line	26	OBJ	I-cell_line
O	O	O	1494	1495	.	.	O	.	O	13	P	O

O	O	O	1496	1500	When	When	B-ADVP	WRB	O	21	VMOD	O
O	O	O	1501	1506	these	these	B-NP	DT	O	4	NMOD	O
O	O	O	1507	1514	patient	patient	I-NP	NN	O	4	NMOD	O
O	O	O	1515	1520	cells	cell	I-NP	NNS	O	5	SUB	O
O	O	O	1521	1525	were	be	B-VP	VBD	O	1	SBAR	O
O	O	O	1526	1533	further	further	I-VP	RB	O	5	VMOD	O
O	O	O	1534	1544	stimulated	stimulate	I-VP	VBN	O	5	VC	O
O	O	O	1545	1547	by	by	B-PP	IN	O	7	VMOD	O
T13	B-Protein	B-Protein	1548	1550	IL	IL	B-NP	NN	B-protein	8	PMOD	B-protein
T13	I-Protein	I-Protein	1550	1551	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T13	I-Protein	I-Protein	1551	1552	2	2	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	1553	1555	in	in	B-ADVP	FW	O	7	VMOD	O
O	O	O	1556	1561	vitro	vitro	I-ADVP	FW	O	12	AMOD	O
O	O	O	1561	1562	,	,	O	,	O	21	P	O
O	O	O	1563	1573	additional	additional	B-NP	JJ	O	16	NMOD	O
O	O	O	1574	1585	differences	difference	I-NP	NNS	O	21	SUB	O
O	O	O	1586	1588	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	1589	1593	STAT	STAT	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1594	1603	induction	induction	I-NP	NN	O	20	NMOD	O
O	O	O	1604	1612	patterns	pattern	I-NP	NNS	O	17	PMOD	O
O	O	O	1613	1617	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1618	1623	noted	note	I-VP	VBN	O	21	VC	O
O	O	O	1623	1624	.	.	O	.	O	21	P	O

O	O	O	1625	1630	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1631	1635	data	datum	I-NP	NNS	O	3	SUB	O
O	O	O	1636	1643	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	O	1644	1651	further	further	B-NP	JJ	O	5	NMOD	O
O	O	O	1652	1663	information	information	I-NP	NN	O	29	NMOD	O
O	O	O	1664	1666	on	on	B-PP	IN	O	5	NMOD	O
O	O	O	1667	1670	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1671	1680	molecular	molecular	I-NP	JJ	O	9	NMOD	O
O	O	O	1681	1687	events	event	I-NP	NNS	O	6	PMOD	O
O	O	O	1688	1697	occurring	occur	B-VP	VBG	O	9	NMOD	O
O	O	O	1698	1700	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1701	1707	immune	immune	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	O	1708	1713	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	1714	1723	generated	generate	B-VP	VBN	O	13	NMOD	O
O	O	O	1724	1731	through	through	B-PP	IN	O	14	VMOD	O
O	O	O	1732	1734	in	in	B-ADVP	FW	O	17	AMOD	O
O	O	O	1735	1739	vivo	vivo	I-ADVP	FW	O	21	NMOD	O
O	O	O	1740	1743	and	and	O	CC	O	21	NMOD	O
O	O	O	1744	1746	in	in	B-NP	FW	O	20	AMOD	O
O	O	O	1747	1752	vitro	vitro	I-NP	FW	O	21	NMOD	O
O	O	O	1753	1767	administration	administration	I-NP	NN	O	15	PMOD	O
O	O	O	1768	1770	of	of	B-PP	IN	O	21	NMOD	O
T14	B-Protein	B-Protein	1771	1773	IL	IL	B-NP	NN	B-protein	24	NMOD	B-protein
T14	I-Protein	I-Protein	1773	1774	-	-	B-NP	HYPH	I-protein	22	PMOD	I-protein
T14	I-Protein	I-Protein	1774	1775	2	2	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	O	1775	1776	,	,	O	,	O	29	P	O
O	O	O	1777	1780	and	and	O	CC	O	29	NMOD	O
O	O	O	1781	1788	further	further	B-NP	JJ	O	29	NMOD	O
O	O	O	1789	1797	document	document	I-NP	NN	O	3	OBJ	O
O	O	O	1798	1802	that	that	B-SBAR	IN	O	29	NMOD	O
O	O	O	1803	1808	there	there	B-NP	EX	O	32	SUB	O
O	O	O	1809	1811	is	be	B-VP	VBZ	O	30	SBAR	O
O	O	O	1812	1815	not	not	O	RB	O	32	VMOD	O
O	O	O	1816	1817	a	a	B-NP	DT	O	36	NMOD	O
O	O	O	1818	1825	precise	precise	I-NP	JJ	O	36	NMOD	O
O	O	O	1826	1836	congruence	congruence	I-NP	NN	O	32	PRD	O
O	O	O	1837	1844	between	between	B-PP	IN	O	36	NMOD	O
O	O	O	1845	1849	PBMC	PBMC	B-NP	NNS	B-cell_type	37	PMOD	B-cell_type
O	O	O	1850	1859	activated	activate	B-VP	VBN	O	38	NMOD	O
O	O	O	1860	1862	in	in	B-ADVP	FW	O	39	VMOD	O
O	O	O	1863	1867	vivo	vivo	I-ADVP	FW	O	40	AMOD	O
O	O	O	1868	1871	and	and	O	CC	O	40	AMOD	O
O	O	O	1872	1874	in	in	B-ADVP	FW	O	40	AMOD	O
O	O	O	1875	1880	vitro	vitro	I-ADVP	FW	O	43	AMOD	O
O	O	O	1881	1883	by	by	B-PP	IN	O	39	VMOD	O
T15	B-Protein	B-Protein	1884	1886	IL	IL	B-NP	NN	B-protein	45	PMOD	B-protein
T15	I-Protein	I-Protein	1886	1887	-	-	O	HYPH	I-protein	46	NMOD	I-protein
T15	I-Protein	I-Protein	1887	1888	2	2	B-NP	CD	I-protein	46	NMOD	I-protein
O	O	O	1888	1889	.	.	O	.	O	3	P	O
